Neoadjuvant Therapy for Advanced Bladder Cancer

Millikan, Randall E.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project (R01)
• Project #: 5R01CA071861-03
• Application #: 2700699
• Study Section: Special Emphasis Panel (SRC (12))
• Program Officer: Xie, Heng
• Project Start: 1996-07-01
• Project End: 2000-04-30
• Budget Start: 1998-05-20
• Budget End: 1999-04-30
• Support Year: 3
• Fiscal Year: 1998

Institution

• Name: University of Texas MD Anderson Cancer Center
• Department: Dentistry
• Type: Other Domestic Higher Education
• DUNS #: 001910777
• City: Houston
• State: TX
• Country: United States
• Zip Code: 77030

Publications

Izawa, Jonathan I; Sweeney, Paul; Perrotte, Paul et al. (2002) Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis. Clin Cancer Res 8:1258-70

Slaton, J W; Inoue, K; Perrotte, P et al. (2001) Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma. Am J Pathol 158:735-43

Inoue, K; Slaton, J W; Karashima, T et al. (2000) The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy. Clin Cancer Res 6:4866-73